4.7 Article

Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites

期刊

NEUROLOGY
卷 78, 期 9, 页码 649-657

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e3182494d51

关键词

-

资金

  1. NIH [NS26636, K23NS047256]
  2. Bachmann-Strauss Dystonia & Parkinson Foundation
  3. Parkinson's Disease Foundation
  4. NIH/NINDS [K23NS047256, K02NS073836]
  5. Michael J. Fox Foundation for Parkinson's Research
  6. Thomas Hartman Foundation for Parkinson's Research
  7. Marcled Foundation
  8. Thomas Hartman Foundation for Parkinson's Research, Inc.
  9. Novartis
  10. Teva Pharmaceutical Industries Ltd.
  11. Allergan, Inc.
  12. Abbott
  13. CIHR
  14. Michael Smith Foundation for Health Research
  15. Pacific Alzheimer Research Foundation
  16. NIH
  17. Parkinson Disease Foundation
  18. Michael J. Fox Foundation
  19. Columbia University
  20. Ceregene and VasSol, Inc.
  21. Dystonia Medical Research Foundation
  22. National Parkinson Foundation
  23. Medical Advisory Board for the Tourette Syndrome Association
  24. Medtronic, Inc.
  25. University of Florida Foundation
  26. Tyler's Hope for a Dystonia Cure
  27. Advanced Neuromodulations Systems
  28. PARRF
  29. PSG
  30. Noscira, Inc.
  31. Lundbeck Inc.
  32. American Academy of Neurology Foundation
  33. Ataxia-Telangiectasia Medical Research Foundation
  34. Ataxia-Telangiectasia Ease Foundation
  35. Athena Diagnostics, Inc.

向作者/读者索取更多资源

Objective: To compare the phenotype of primary-appearing dystonia due to variant ataxia-telangiectasia (A-T) with that of other dystonia ascertained for genetics research. Methods: Movement disorder specialists examined 20 Canadian Mennonite adult probands with primary-appearing dystonia, as well as relatives in 4 families with parent-child transmission of dystonia. We screened for the exon 43 c.6200 C>A (p. A2067D) ATM mutation and mutations in DYT1 and DYT6. Clinical features of the individuals with dystonia who were harboring ATM mutations were compared with those of individuals without mutations. Result: Genetic analysis revealed a homozygous founder mutation in ATM in 13 members from 3 of the families, and no one harbored DYT6 or DYT1 mutations. Dystonia in ATM families mimicked other forms of early-onset primary torsion dystonia, especially DYT6, with prominent cervical, cranial, and brachial involvement. Mean age at onset was markedly younger in the patients with variant A-T (n = 12) than in patients with other dystonia (n = 23), (12 years vs 40 years, p < 0.05). The patients with A-T were remarkable for the absence of notable cerebellar atrophy on MRI, lack of frank ataxia on examination, and absence of ocular telangiectasias at original presentation, as well as the presence of prominent myoclonus-dystonia in 2 patients. Many also developed malignancies. Conclusion: Ataxia and telangiectasias may not be prominent features of patients with variant A-T treated for dystonia in adulthood, and variant A-T may mimic primary torsion dystonia and myoclonus-dystonia. Neurology (R) 2012;78:649-657

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据